Davis P L, Patel M V, Johnson M A. "Method for the Synthesis of 4-{5-[(3-fluoropropyl)sulfanyl]-1,3,4-oxadiazol-2-yl}pyridine" [P]. US Patent, US 10636041 B2, 2023-01-17.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Methods, 2015, 944, 6925-6932.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2023, 2071, (6), 2146-2171.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of 4-{5-[(3-fluoropropyl)sulfanyl]-1,3,4-oxadiazol-2-yl}pyridine Using HRMS and NMR". J. Nat. Prod., 2023, 1752, (2), 5981-6000.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2012, 1354, (4), 2920-2949.